<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Sowmyashree Gangaraju</style></author><author><style face="normal" font="default" size="100%">Bhagyalakshmi Manjappa</style></author><author><style face="normal" font="default" size="100%">Girish Kesturu Subbaiah</style></author><author><style face="normal" font="default" size="100%">Kemparaju Kempaiah</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Jackfruit (Artocarpus heterophyllus) seed extract exhibits fibrino(geno)lytic activity</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Fibrino(geno)lysis</style></keyword><keyword><style  face="normal" font="default" size="100%">Hemostasis</style></keyword><keyword><style  face="normal" font="default" size="100%">Jackfruit</style></keyword><keyword><style  face="normal" font="default" size="100%">Moraceae</style></keyword><keyword><style  face="normal" font="default" size="100%">Non-hemorrhagic</style></keyword><keyword><style  face="normal" font="default" size="100%">Serine/cysteine protease.</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">09th Mar, 2015</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">7</style></volume><pages><style face="normal" font="default" size="100%">171-177</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Objective:&lt;/strong&gt; The current study assesses the fibrinogen and fibrin clot hydrolyzing activities of aqueous seed extract of Jackfruit (AqSEJ).&lt;strong&gt; Methods:&lt;/strong&gt; The protein banding pattern of AqSEJ (100 &amp;mu;g) was analyzed on SDS-PAGE. The proteolytic activity of AqSEJ was confirmed by spectrophotometer and zymography experiments. Fibrinogen, fibrin and plasma protein hydrolyzing activities of AqSEJ were analyzed on SDS-PAGE under reduced conditions. Plasminogen activation and indirect hemolytic activities was analyzed using spectrophotometer. The non-toxic property of AqSEJ was tested by edema, hemorrhage in experimental mice. &lt;strong&gt;Results: &lt;/strong&gt;AqSEJ exhibited proteolytic activity and the specific activity was found to be 1.04 units/mg/min. Furthermore, AqSEJ non-specifically hydrolyzed A&amp;alpha;, followed by B&amp;beta; and &amp;gamma; chains of human fibrinogen and specifically hydrolyzed &amp;alpha; polymer and &amp;alpha; chain of partially cross linked human fibrin clot without affecting &amp;beta; chain and &amp;gamma;-&amp;gamma; dimer even up to the tested dose of 30 &amp;micro;g for the incubation period of 8 hours. Importantly, AqSEJ did not hydrolyze other plasma proteins and devoid of plasminogen activation property. The proteolytic activity of AqSEJ was completely neutralized by PMSF and IAA, while EDTA, EGTA, 1,10-Phenanthroline did not, suggesting the presence of serine and cysteine family proteases. Moreover, AqSEJ did not cause edema and hemorrhage in experimental mice up to the tested dose of 200 &amp;micro;g and nontoxic to RBC cells. &lt;strong&gt;Conclusion: &lt;/strong&gt;AqSEJ hydrolyzes fibrinogen and fibrin clot and non-toxic in nature. Hence, this work showcases the potential applications of Jack fruit seed proteases in the treatment of thrombotic disorders.&lt;/p&gt;&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Key words:&lt;/strong&gt; Fibrino(geno)lysis, Hemostasis, Jackfruit, Moraceae, Non-hemorrhagic, Serine/cysteine protease.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">3</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">171</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Sowmyashree Gangaraju&lt;sup&gt;1&lt;/sup&gt;, Bhagyalakshmi Manjappa&lt;sup&gt;1&lt;/sup&gt;, Girish Kesturu Subbaiah&lt;sup&gt;1&lt;/sup&gt;, Kemparaju Kempaiah&lt;sup&gt;2&lt;/sup&gt;, Rangaiah Shashidhara Murthy&lt;sup&gt;3&lt;/sup&gt;, Jane Hoover Plow&lt;sup&gt;4&lt;/sup&gt;, Sebastin Santhosh Martin&lt;sup&gt;5&lt;/sup&gt;, Manohar Shinde&lt;sup&gt;1&lt;/sup&gt;, and Devaraja Sannaningaiah&lt;sup&gt;1*&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;1,*&lt;/sup&gt;Department of Studies and Research in Biochemistry and Centre for Bioscience and Innovation, Tumkur University, Tumkur- 572103, India&lt;/p&gt;&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Departments of Studies in Biochemistry, University of Mysore, Manasagangothry, Mysore-570 006, India&lt;/p&gt;&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Department of Pharmaceutical Sciences, Philadelphia College of Osteopathic Medicine. Atlanta, Georgia, USA&lt;/p&gt;&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Joseph J. Jacobs Center for Thrombosis and Vascular Biology, Department of Molecular Cardiology, Cleveland Clinic Lerner Research Institute, Cleveland, OH&lt;/p&gt;&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;5&lt;/sup&gt;Department of Medical Biochemistry and Biophysics, Karolinska Institute, SE 17177, Stockhlm, Sweden&lt;/p&gt;</style></auth-address></record></records></xml>